Abstract
Viral infections stimulate the JAK/STAT signaling pathway induced by interferon type I (IFN-±/²) and increase the expression of a class of effector molecules encoded by Interferon-Stimulated Genes (ISGs). These effectors molecules inhibit viral replication and its dissemination to non-infected acceptor cells. Despite this ability to activate the antiviral state, low clinical response to I…